S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Closing prices for crude oil, gold and other commodities
MarketBeat Week in Review – 4/15 - 4/19
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Closing prices for crude oil, gold and other commodities
MarketBeat Week in Review – 4/15 - 4/19
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Closing prices for crude oil, gold and other commodities
MarketBeat Week in Review – 4/15 - 4/19
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Closing prices for crude oil, gold and other commodities
MarketBeat Week in Review – 4/15 - 4/19
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion

Immatics (IMTXW) Competitors

$2.39
0.00 (0.00%)
(As of 04/19/2024 ET)

IMTXW vs. ATNFW, SXTPW, DRTSW, APLMW, ARTLW, BCDAW, BCTXW, CDIOW, CTCXW, and SAVAW

Should you be buying Immatics stock or one of its competitors? The main competitors of Immatics include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), Artelo Biosciences (ARTLW), BioCardia (BCDAW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), and Cassava Sciences (SAVAW). These companies are all part of the "biotechnology" industry.

Immatics vs.

180 Life Sciences (NASDAQ:ATNFW) and Immatics (NASDAQ:IMTXW) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability, analyst recommendations, media sentiment and community ranking.

180 Life Sciences and Immatics both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
ImmaticsN/AN/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Immatics$54.00MN/AN/AN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
180 Life Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Immatics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

In the previous week, Immatics had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 1 mentions for Immatics and 0 mentions for 180 Life Sciences. 180 Life Sciences' average media sentiment score of 0.49 beat Immatics' score of 0.00 indicating that Immatics is being referred to more favorably in the news media.

Company Overall Sentiment
180 Life Sciences Neutral
Immatics Neutral

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Immatics N/A N/A N/A

Summary

Immatics beats 180 Life Sciences on 3 of the 3 factors compared between the two stocks.

Get Immatics News Delivered to You Automatically

Sign up to receive the latest news and ratings for IMTXW and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IMTXW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IMTXW vs. The Competition

MetricImmaticsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$357.69M$4.84B$7.32B
Dividend YieldN/A3.48%2.93%3.99%
P/E RatioN/A218.02182.9215.24
Price / SalesN/A14,375.242,460.4181.79
Price / CashN/A11.6546.3134.42
Price / BookN/A5.414.564.15
Net IncomeN/A-$22.12M$103.92M$214.00M
7 Day PerformanceN/A-1.71%-4.51%-3.52%
1 Month Performance-34.70%-2.93%-6.70%-5.50%
1 Year Performance58.28%51.14%7.73%3.52%

Immatics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATNFW
180 Life Sciences
0 of 5 stars
$0.01
flat
N/A-57.1%$0.00N/A0.004Gap Up
SXTPW
60 Degrees Pharmaceuticals
0 of 5 stars
$0.11
flat
N/AN/A$0.00$253,573.000.002Positive News
DRTSW
Alpha Tau Medical
0 of 5 stars
$0.24
+9.3%
N/AN/A$0.00N/A0.00121News Coverage
Gap Up
APLMW
Apollomics
0 of 5 stars
$0.02
-11.2%
N/A-73.7%$0.00N/A0.0059Gap Up
ARTLW
Artelo Biosciences
0 of 5 stars
$0.02
flat
N/A-79.4%$0.00N/A0.005Positive News
BCDAW
BioCardia
0 of 5 stars
$0.02
flat
N/AN/A$0.00$477,000.000.0030Positive News
Gap Down
BCTXW
BriaCell Therapeutics
0 of 5 stars
$0.96
-5.0%
N/A-68.4%$0.00N/A0.0016Positive News
Gap Down
CDIOW
Cardio Diagnostics
0 of 5 stars
$0.08
flat
N/A-66.0%$0.00$17,065.000.007Positive News
Gap Down
CTCXW
Carmell
0 of 5 stars
$0.08
+14.3%
N/AN/A$0.00$3.73M0.009Positive News
SAVAW
Cassava Sciences
0 of 5 stars
$0.72
-17.2%
N/AN/A$0.00N/A0.0029Positive News
Gap Down

Related Companies and Tools

This page (NASDAQ:IMTXW) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners